Philippe Beuzeboc

12.9k citations
248 papers · 8.0k · 4 hit papers · h-index 48

Impact in

    • Breast Cancer Treatment Studies
  • Oncology top 0.5%
    • HER2/EGFR in Cancer Research
    • Bone health and treatments
    • Cancer Treatment and Pharmacology

Papers in

    • Prostate Cancer Treatment and Research 74
    • Prostate Cancer Diagnosis and Treatment 30
    • Cancer Treatment and Pharmacology 37
    • HER2/EGFR in Cancer Research 16
    • Cancer Immunotherapy and Biomarkers 13

Philippe Beuzeboc

232 papers receiving 7.8k citations

Philippe Beuzeboc's Hit Papers

TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomes 2024 · 45 citations
450+4+9Years since publication100200300400

Peers

Philippe Beuzeboc
Comparison fields: 5 of 119
  • Cancer Research 2.0k
  • Oncology 3.0k
  • Pulmonary and Respiratory Medicine 2.8k
  • Radiology, Nuclear Medicine and Imaging 961
  • Pathology and Forensic Medicine 661
Replace Tarek Sahmoud with:
Tarek Sahmoud Belgium
Mikhail Lichinitser Russia
I. Bodrogi Hungary
Frédéric Rolland France
Lee S. Rosen United States
Arnoud J. Templeton Switzerland
Maciej Krzakowski Poland
Sergio Bracarda Italy
Clara C. Chen United States
Daniel Castellano Spain
Philippe Beuzeboc relative to Tarek Sahmoud Belgium Tarek Sahmoud's profile →
Citations per field
00.5×2.9×
Tarek Sahmoud · 1×
Citations per year

Countries citing papers authored by Philippe Beuzeboc

Since Specialization
Citations

This map shows the geographic impact of Philippe Beuzeboc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Beuzeboc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Beuzeboc more than expected).

Fields of papers citing papers by Philippe Beuzeboc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Beuzeboc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Beuzeboc. The network helps show where Philippe Beuzeboc may publish in the future.

Co-authors

The 25 scholars most cited alongside Philippe Beuzeboc, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Philippe Beuzeboc Line = papers co-authored together Philippe Beuzeboc links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 248 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials
Hit paper breakdown →
2012446
2
TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors
Hit paper breakdown →
2021367
3 1994356
4 2007354
5 1996351
6
Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial
Hit paper breakdown →
2015327
7 2003273
8 2009175
9 2009175
10 2008141
11 2009139
12 1989138
13 1995135
14 2014135
15 2001128
16 1996123
17 2011115
18 1996112
19 2005110
20 1999109

About Philippe Beuzeboc

Philippe Beuzeboc is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 248 papers that have together received 8.0k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (74 papers), Cancer Treatment and Pharmacology (37 papers), Bladder and Urothelial Cancer Treatments (35 papers), Prostate Cancer Diagnosis and Treatment (30 papers), Breast Cancer Treatment Studies (27 papers), Radiopharmaceutical Chemistry and Applications (21 papers), HER2/EGFR in Cancer Research (16 papers) and Cancer Immunotherapy and Biomarkers (13 papers). The work is most often cited by research in Cancer Research (2.0k citations), Oncology (3.0k citations), Pulmonary and Respiratory Medicine (2.8k citations), Radiology, Nuclear Medicine and Imaging (961 citations) and Pathology and Forensic Medicine (661 citations). Philippe Beuzeboc has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include P Pouillart, Stéphane Oudard, Thierry Dorval, Bernard Asselain, Suzy Scholl, Karim Fizazi, M Jouve, Jean‐Yves Pierga, T Palangié and J.C. Durand. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Cancer and European Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact